Publications by authors named "Diana M Ciuculete"

DNA methylation shifts in Hypothalamic-pituitary-adrenal (HPA) axis related genes is reported in psychiatric disorders including hypersexual disorder. This study, comprising 20 dexamethasone suppression test (DST) non-suppressors and 73 controls, examined the association between the HPA axis dysregulation, shifts in DNA methylation of HPA axis related genes and importantly, gene expression. Individuals with cortisol level ≥ 138 nmol/l, after the low dose (0.

View Article and Find Full Text PDF

This study explores potential associations between the methylation of promoter-associated CpG sites of the toll-like receptor (TLR)-family, plasma levels of pro-inflammatory proteins and depressive symptoms in young female psychiatric patients. Ratings of depressive symptoms and blood samples were obtained from 92 young women seeking psychiatric care. Methylation of 32 promoter-associated CpG sites in TLR1 to TLR10 was analysed using the Illumina Infinium Methylation EPIC BeadChip.

View Article and Find Full Text PDF

Background: Little is known about how genetics and epigenetics interplay in depression. Evidence suggests that genetic variants may change vulnerability to depression by modulating DNA methylation (DNAm) and non-coding RNA (ncRNA) levels. Therefore, the aim of the study was to investigate the effect of the genetic variation, previously identified in the largest genome-wide association study for depression, on proximal DNAm and ncRNA levels.

View Article and Find Full Text PDF

SLC18B1 is a sister gene to the vesicular monoamine and acetylcholine transporters, and the only known polyamine transporter, with unknown physiological role. We reveal that Slc18b1 knock out mice has significantly reduced polyamine content in the brain providing the first evidence that Slc18b1 is functionally required for regulating polyamine levels. We found that this mouse has impaired short and long term memory in novel object recognition, radial arm maze and self-administration paradigms.

View Article and Find Full Text PDF

Patients with bipolar disorder (BD) show higher frequency of obesity and type 2 diabetes (T2D), but the underlying genetic determinants and molecular pathways are not well studied. Using large publicly available datasets, we (1) conducted a gene-based analysis using MAGMA to identify genes associated with BD and body mass index (BMI) or T2D and investigated their functional enrichment; and (2) performed two meta-analyses between BD and BMI, as well as BD and T2D using Metasoft. Target druggability was assessed using the Drug Gene Interaction Database (DGIdb).

View Article and Find Full Text PDF
Article Synopsis
  • Metformin is a common medication for controlling blood sugar that may also affect DNA methylation in various diseases, highlighting its potential benefits beyond diabetes treatment.
  • A study examined how short-term metformin administration influenced DNA methylation profiles in healthy participants, identifying 125 differentially methylated regions, particularly in genes linked to energy regulation, inflammation, tumor development, and neurodegenerative diseases.
  • The results suggest that DNA methylation may play a role in metformin's therapeutic effects, paving the way for further research into its mechanisms and potential new applications.
View Article and Find Full Text PDF
Article Synopsis
  • Generalized anxiety disorder (GAD) is common in adolescents, and early detection could help prevent serious mental health issues later on.
  • The study examined the relationship between epigenetic changes (specifically DNA methylation) in blood and the likelihood of developing GAD in 221 healthy adolescents, finding one significant methylation site linked to higher risk.
  • The identified CpG site (cg16333992) is related to the STK32B gene, which plays a role in stress responses, suggesting that DNA methylation can indicate potential anxiety risk in young people.
View Article and Find Full Text PDF

Hypersexual Disorder (HD) defined as non-paraphilic sexual desire disorder with components of compulsivity, impulsivity and behavioral addiction, and proposed as a diagnosis in the DSM 5, shares some overlapping features with substance use disorder including common neurotransmitter systems and dysregulated hypothalamic-pituitary-adrenal (HPA) axis function. In this study, comprising 67 HD male patients and 39 male healthy volunteers, we aimed to identify HPA-axis coupled CpG-sites, in which modifications of the epigenetic profile are associated with hypersexuality. The genome-wide methylation pattern was measured in whole blood using the Illumina Infinium Methylation EPIC BeadChip, measuring the methylation state of over 850K CpG sites.

View Article and Find Full Text PDF